Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.

Saved in:
Bibliographic Details
Title: Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.
Authors: Lam JS (AUTHOR), Benson MC (AUTHOR), O'Donnell MA (AUTHOR), Sawczuk A (AUTHOR), Gavazzi A (AUTHOR), Wechsler MH (AUTHOR), Sawczuk IS (AUTHOR), Lam, John S1 (AUTHOR), Benson, Mitchell C (AUTHOR), O'Donnell, Michael A (AUTHOR), Sawczuk, Alexandra (AUTHOR), Gavazzi, Anna (AUTHOR), Wechsler, Michael H (AUTHOR), Sawczuk, Ihor S (AUTHOR)
Source: Urologic Oncology. Sep2003, Vol. 21 Issue 5, p354-360. 7p.
Database: Academic Search Ultimate
Description
ISSN:10781439
DOI:10.1016/s1078-1439(03)00012-7